Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-2478 + Bortezomib in Relapsed/Refractory Multiple Myeloma
NCT01063907Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Mar 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of KW-2478 in multiple myeloma (MM), sponsored by Kyowa Kirin. Started Mar 2010; status: completed.
02
Drugs
KW-2478
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01063907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063907.